Reliance Industries To Roll Out Genome Testing Kit Soon: Report

Mukesh Ambani-backed Reliance Industries has forayed into genome testing and its test kit will be rolled out soon. The kit is developed by the Bengaluru-based Strand Life Sciences, which was acquired by Reliance Industries in 2021 and has 80 per cent stake in the firm.
As per a report from Allied Market Research, the market for global genetic testing was valued at $12.7 billion in 2019 and is anticipated to touch $21.3 billion by 2027
Outlook covers the latest India news, analysis, business news and long-form stories on culture, money market and personal finance. Read India's best online magazine.

FDA Authorizes First Single-Use, PCR Quality Over the Counter (OTC) LUCIRA CHECK IT™ COVID-19 At-Home Test. Available Now.

Reliance to roll out affordable genome sequencing test soon

RIL to roll out cheapest genome sequencing kits priced $150 - Industry News

Reliance project.pdf

Our Research & Development - Reliance Industries

Latest & Updated Business News from India & World - Live News

Mukesh Ambani's Reliance to roll out genome sequencing kit priced Rs 12,000; all you need to know

How can lessons from the COVID-19 pandemic enhance antimicrobial resistance surveillance and stewardship? - The Lancet Infectious Diseases

Sahil Patil on LinkedIn: Reliance Industries To Roll Out Genome

Mukesh Ambani to foray into genome testing with ₹12,000 kit - The Hindu BusinessLine

Feluda paper strip test kit to be available in 8 metro cities: Full list

Special Report: COVID opens new doors for China's gene giant

Mukesh Ambani's Reliance to foray into genetic mapping with Rs-12,000 test - BusinessToday